References
- SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
- NovaraGFicarraVMocellinSSystematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomyEur Urol201262338240422749851
- FreedlandSJHumphreysEBMangoldLARisk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomyJAMA2005294443343916046649
- FossatiNKarnesRJCozzariniCAssessing the optimal timing for early salvage radiation therapy in patients with prostate-specific antigen rise after radical prostatectomyEur Urol201669472873326497924
- AbugharibAJacksonWCTumatiVVery early salvage radiotherapy improves distant metastasis-free survivalJ Urol2017197366266827614333
- MessingEMManolaJYaoJImmediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomyLancet Oncol20067647247916750497
- TilkiDMandelPSchlommTExternal validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohortJ Urol201519361970197525498570
- PunnenSFreedlandSJPrestiJCMulti-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomyEur Urol20146561171117723587869
- WalzJChunFKKleinEANomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancerJ Urol2009181260160819084864
- HansenJBianchiMSunMPercentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason scoreBJU Int2014113339940724053339
- KellyRSVander HeidenMGGiovannucciEMucciLAMetabolomic biomarkers of prostate cancer: prediction, diagnosis, progression, prognosis, and recurrenceCancer Epidemiol Biomarkers Prev201625688790627197278
- MaxeinerAAdkinsCBZhangYRetrospective analysis of prostate cancer recurrence potential with tissue metabolomic profilesProstate201070771071720017167
- McdunnJELiZAdamKPMetabolomic signatures of aggressive prostate cancerProstate201373141547156023824564
- StablerSKoyamaTZhaoZSerum methionine metabolites are risk factors for metastatic prostate cancer progressionPLoS One201168e2248621853037
- LaneLAQianXNieSSERS nanoparticles in medicine: from label-free detection to spectroscopic taggingChem Rev201511519104891052926313254
- BastúsNGComengeJPuntesVPuntesVKinetically controlled seeded growth synthesis of citrate-stabilized gold nanoparticles of up to 200 nm: size focusing versus Ostwald ripeningLangmuir20112717110981110521728302
- JermynMDesrochesJAubertinKA review of Raman spectroscopy advances with an emphasis on clinical translation challenges in oncologyPhys Med Biol20166123R370R40027804917
- AubertinKTrinhVQJermynMMesoscopic characterization of prostate cancer using Raman spectroscopy: potential for diagnostics and therapeuticsBJU Int2018122232633629542855
- SchlückerSSurface-enhanced Raman spectroscopy: concepts and chemical applicationsAngew Chem Int Ed Engl201453194756479524711218
- FengSChenRLinJNasopharyngeal cancer detection based on blood plasma surface-enhanced Raman spectroscopy and multivariate analysisBiosens Bioelectron201025112414241920427174
- FengSChenRLinJGastric cancer detection based on blood plasma surface-enhanced Raman spectroscopy excited by polarized laser lightBiosens Bioelectron20112673167317421227679
- FengSLinDLinJBlood plasma surface-enhanced Raman spectroscopy for non-invasive optical detection of cervical cancerAnalyst2013138143967397423529624
- XiaoRZhangXRongZNon-invasive detection of hepatocellular carcinoma serum metabolic profile through surface-enhanced Raman spectroscopyNanomedicine20161282475248427520725
- ShaoXPanJWangYEvaluation of expressed prostatic secretion and serum using surface-enhanced Raman spectroscopy for the noninvasive detection of prostate cancer, a preliminary studyNanomedicine20171331051105927979746
- FengJGangFLiXPlasma cell-free DNA and its DNA integrity as biomarker to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate-specific antigenInt Urol Nephrol20134541023102823779229
- YinCLuoCHuWDingXYuanCWangFQuantitative and qualitative analysis of circulating cell-free dna can be used as an adjuvant tool for prostate cancer screening: a meta-analysisDisease Markers201620164112
- BastianPJPalapattuGSYegnasubramanianSPrognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomyClin Cancer Res20071318 Pt 15361536717875764
- WroclawskiMLSerpa-NetoAFonsecaFLCell-free plasma DNA as biochemical biomarker for the diagnosis and follow-up of prostate cancer patientsTumour Biol20133452921292723715778
- Di MeoABartlettJChengYPasicMDYousefGMLiquid biopsy: a step forward towards precision medicine in urologic malignanciesMol Cancer20171618028410618
- WuXDanielsGLeePMonacoMELipid metabolism in prostate cancerAm J Clin Exp Urol20142211112025374912